Jnj-26483327
5-bromo-18-methoxy-10-methyl-16-oxa-2,10,21,23-tetrazatetracyclo[15.6.2.03,8.020,24]pentacosa-1(23),3(8),4,6,17,19,21,24-octaene
Molecular Identity
Jnj-26483327
5-bromo-18-methoxy-10-methyl-16-oxa-2,10,21,23-tetrazatetracyclo[15.6.2.03,8.020,24]pentacosa-1(23),3(8),4,6,17,19,21,24-octaene
PubChem CID: 11952856
2D Structure
Properties
C22H25BrN4O2
Molecular Formula
457.40
Molecular Weight
g/mol
456.1161
Exact Mass
Da
4.7
XLogP
Drug-like (Lipinski: < 5)
59.5
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
6
H-Bond Acceptors
513
Complexity
SMILES
Canonical SMILES
SMILES: CN1CCCCCOC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C1)C=CC(=C4)Br)OCIsomeric SMILES
SMILES: CN1CCCCCOC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C1)C=CC(=C4)Br)OCSynonyms(20)
807640-87-5JNJ-26483327JNJ 2648332716720VER1H17-Bromo-1,8,9,10,11,12,13,14-octahydro-20-methoxy-13-methyl-4,6-ethenopyrimido(4,5-b)(6,1,12)benzoxadiazacyclopentadecine4,6-Ethenopyrimido(4,5-b)(6,1,12)benzoxadiazacyclopentadecine, 17-bromo-1,8,9,10,11,12,13,14-octahydro-20-methoxy-13-methyl-4,6-Ethenopyrimido[4,5-b][6,1,12]benzoxadiazacyclopentadecine, 17-bromo-1,8,9,10,11,12,13,14-octahydro-20-methoxy-13-methyl-RefChem:150530TKI JNJ-26483327Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327BGB-102CHEMBL310973835-bromo-17-methoxy-5-methyl-11-oxa-2,5-diaza-1(4,6)-quinazolina-3(1,2)-benzenacycloundecaphaneJNJ 26483327 [WHO-DD]UNII-16720VER1H
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Jnj-26483327
Loading drug network...